The effect of sweet almond oil and violet oil on inflammatory factors in breast cancer patients

The effect of sweet almond oil and violet oil on inflammatory factors in breast cancer patients treated with capecitabine

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250308064991N1

Enrollment

Registered

2025-04-08

Start date

2025-04-04

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer. Malignant neoplasm of unspecified site of unspecified female breast

Interventions

Intervention 1: Control group: In breast cancer patients will first have a blood sample taken as a control. Then, for one month, a topical medication containing sweet almond will be applied twice dai

Eligibility

Sex/Gender

Female

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Consent to participate in the study Absence of metastasis at diagnosis Anatomopathological diagnosis of breast cancer Age range 18 to 65 years Absence of violet oil, topical almond oil at the time of entry into the study

Exclusion criteria

Exclusion criteria: Non-breast cancers Use of violet oil, topical almond oil at the time of entry into the study

Design outcomes

Primary

Measure	Time frame
IL- 1ß. Timepoint: Before and after the intervention. Method of measurement: Measuring the amount in the patient's blood.;IL- 4. Timepoint: Before and after the intervention. Method of measurement: Measuring the amount in the patient's blood.;TNF-a. Timepoint: Before and after the intervention. Method of measurement: Measuring the amount in the patient's blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Majid Ghazanfari

Sabzevar University of Medical Sciences

everlastingmajid@gmail.com+98 51 4401 8101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026